Take a look at some of Thursday's morning movers:
News Corp. - The company’s board has officially approved a split of the company in two, separating out the film and TV businesses. Shareholders will get one share in the new, second company for each share they hold in the current News Corp.
Family Dollar – The low-price retailer reported quarterly profit of $1.06 per share for its latest quarter, one cent below estimates. The company says its new initiatives to broaden product offerings had little impact in the quarter, but should start to do so in the current quarter.
JPMorgan Chase - The New York Times says the losses from the bank’s derivatives trades may reach as high as $9 billion, compared to initial estimates of about $2 billion.
Big Banks - Separately, Citi analysts have cut second quarter earnings estimates and price targets for JPMorgan Chase, as well as Bank of America, Goldman Sachs, and Morgan Stanley.
RadioShack - Chief merchandise officer Scott Young has resigned from the electronics retailer, according to a U.S. Securities and Exchange Commission filing. Young took that job in April 2010.
Comcast - The Federal Communications Commission has resolved a compliance investigation with conditions related to Comcast’s purchase of a majority stake in NBCUniversal (the parent of CNBC and CNBC.com). The resolution extends by a year the requirement that Comcast offer a reasonably priced broadband service option to consumers who do not buy cable service from the company.
Banks Involved in Libor Probe - U.K. Finance Minister George Osborne says four banks besides Barclays are being probed in the ongoing Libor manipulation case: HSBC, UBS, Citigroup, and Royal Bank of Scotland. Barclays had agreed to pay $454 million yesterday to settle the case with U.K. and U.S. authorities.
AMR – Union leaders at the American Airlines parent will let pilots vote on a company proposal to slash spending on labor, avoiding a bankruptcy judge ruling that could have imposed even tougher terms on the pilots.
Onyx Pharmaceuticals - The U.S. Food and Drug Administration has granted a priority review to Bayer’s new colorectal cancer drug. Onyx is Bayer’s U.S. marketing partner for the drug. A priority review cuts the usual 10 to 12 month period down to about six months.
Boeing – European rival Airbus is planning to build its first U.S. plant in Mobile, Alabama. Airbus would use the plant to assemble its A320 jet.
Nasdaq OMX – Nasdaq will unveil its compensation plan related to the trouble-plagued Facebookinitial public offering to the SEC next week, according to reports. Nasdaq has previously proposed to offer cash and discounted trading fees to cover $40 million in losses.
—By CNBC’s Peter Schacknow
Questions? Comments? Email us at email@example.com